How do Selective Serotonin Reuptake Inhibitors (SSRIs) impact tumor growth and T cell antitumor immunity?
Label:chem
Topic
SSRIs are a class of antidepressants that block SERT.
Answer
SERT-blocking Selective Serotonin Reuptake Inhibitors (SSRIs) enhance CD8 T cell antitumor immunity and significantly suppress tumor growth. They can also synergize with anti-PD-1 treatment, positioning them as potential cancer immunotherapeutics.
Return to Home
Chemical List
Knowledge you may be interested in